학술논문
Safety, tolerability, and efficacy of orally administered atogepant for the prevention of episodic migraine in adults: a double-blind, randomised phase 2b/3 trial
Document Type
Article
Author
Source
In The Lancet Neurology September 2020 19(9):727-737
Subject
Language
ISSN
1474-4422